Access cutting-edge brain tumor treatment through this clinical trial at a research site in Tacoma. Study-provided care at no cost to qualified participants.
Access brain tumor specialists in Tacoma at no cost
This study follows strict safety protocols and ethical guidelines
All study-related brain tumor treatment provided free
This multi-site, Phase 1/2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO212 alone for the treatment of patients with radiographically-confirmed progression of Astrocytoma IDH- mutant, Glioblastoma IDH-wildtype, and the safety, pharmacokinetics and efficacy of a repeated dose regimen of NEO212 when given with select SOC for the treatment of solid tumor patients with radiographically confirmed uncontrolled metastases
Sponsor: Neonc Technologies, Inc.
Check if you qualify for this brain tumor clinical trial in Tacoma, WA
If you're searching for brain tumor treatment options in Tacoma, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tacoma research site is actively enrolling participants for this clinical trial. You'll receive care from experienced brain tumor specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.